Skip to Main Content

Author Details

Kun-Liang Guan
University of California San Diego
1988
432
145
PMIDPaper TitleJournal TitlePublished Year
36919698The immunometabolite itaconate stimulates OXGR1 to promote mucociliary clearance during the pulmonary innate immune response.J Clin Invest2023
37932786Targeting FLT3-TAZ signaling to suppress drug resistance in blast phase chronic myeloid leukemia.Mol Cancer2023
37739954YAP silencing by RB1 mutation is essential for small-cell lung cancer metastasis.Nat Commun2023
37580748Correction: Reprogramming anchorage dependency by adherentâ¿¿toâ¿¿suspension transition promotes metastatic dissemination.Mol Cancer2023
37308716Insights into recent findings and clinical application of YAP and TAZ in cancer.Nat Rev Cancer2023
36998106The Arf family GTPases: Regulation of vesicle biogenesis and beyond.Bioessays2023
37115931Targeting IRG1 reverses the immunosuppressive function of tumor-associated macrophages and enhances cancer immunotherapy.Sci Adv2023
36991428Reprogramming anchorage dependency by adherent-to-suspension transition promotes metastatic dissemination.Mol Cancer2023
36919698The immunometabolite itaconate stimulates OXGR1 to promote mucociliary clearance during the pulmonary innate immune response.J Clin Invest2023
37739954YAP silencing by RB1 mutation is essential for small-cell lung cancer metastasis.Nat Commun2023
37580748Correction: Reprogramming anchorage dependency by adherentâ¿¿toâ¿¿suspension transition promotes metastatic dissemination.Mol Cancer2023
37932786Targeting FLT3-TAZ signaling to suppress drug resistance in blast phase chronic myeloid leukemia.Mol Cancer2023
36991428Reprogramming anchorage dependency by adherent-to-suspension transition promotes metastatic dissemination.Mol Cancer2023
37115931Targeting IRG1 reverses the immunosuppressive function of tumor-associated macrophages and enhances cancer immunotherapy.Sci Adv2023
37308716Insights into recent findings and clinical application of YAP and TAZ in cancer.Nat Rev Cancer2023
36998106The Arf family GTPases: Regulation of vesicle biogenesis and beyond.Bioessays2023
34265423The two sides of Hippo pathway in cancer.Semin Cancer Biol2022
35844135Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.EMBO J2022
36348011TET2 deficiency sensitizes tumor cells to statins by reducing HMGCS1 expression.Oncogene2022
36347846The Hippo signalling pathway and its implications in human health and diseases.Signal Transduct Target Ther2022
35613278The Hippo pathway mediates Semaphorin signaling.Sci Adv2022
36064579ALK fusion promotes metabolic reprogramming of cancer cells by transcriptionally upregulating PFKFB3.Oncogene2022
35788180Hippo pathway regulation by phosphatidylinositol transfer protein and phosphoinositides.Nat Chem Biol2022
36319062Tanshinone functions as a coenzyme that confers gain of function of NQO1 to suppress ferroptosis.Life Sci Alliance2022
35535466The multifaceted role of autophagy in cancer.EMBO J2022
36400006Acetyl-CoA, protein acetylation, and liver cancer.Mol Cell2022
36446024A Class of Disulfide Compounds Suppresses Ferroptosis by Stabilizing GPX4.ACS Chem Biol2022
35535164Protocols for measuring phosphorylation, subcellular localization, and kinase activity of Hippo pathway components YAP and LATS in cultured cells.STAR Protoc2022
34265423The two sides of Hippo pathway in cancer.Semin Cancer Biol2022
35294906Rheb regulates nuclear mTORC1 activity independent of farnesylation.Cell Chem Biol2022
35292350Loss of SIRT5 promotes bile acid-induced immunosuppressive microenvironment and hepatocarcinogenesis.J Hepatol2022
35256775Itaconate inhibits TET DNA dioxygenases to dampen inflammatory responses.Nat Cell Biol2022
35217640Transcriptional repression of estrogen receptor alpha by YAP reveals the Hippo pathway as therapeutic target for ER<sup>+</sup> breast cancer.Nat Commun2022
34706158Co-occurrence of BAP1 and SF3B1 mutations in uveal melanoma induces cellular senescence.Mol Oncol2022
35177479Rag GTPases regulate cellular amino acid homeostasis.Proc Natl Acad Sci U S A2022
35844135Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.EMBO J2022
35613278The Hippo pathway mediates Semaphorin signaling.Sci Adv2022
35535466The multifaceted role of autophagy in cancer.EMBO J2022
35535164Protocols for measuring phosphorylation, subcellular localization, and kinase activity of Hippo pathway components YAP and LATS in cultured cells.STAR Protoc2022
35788180Hippo pathway regulation by phosphatidylinositol transfer protein and phosphoinositides.Nat Chem Biol2022
36446024A Class of Disulfide Compounds Suppresses Ferroptosis by Stabilizing GPX4.ACS Chem Biol2022
36400006Acetyl-CoA, protein acetylation, and liver cancer.Mol Cell2022
36064579ALK fusion promotes metabolic reprogramming of cancer cells by transcriptionally upregulating PFKFB3.Oncogene2022
36348011TET2 deficiency sensitizes tumor cells to statins by reducing HMGCS1 expression.Oncogene2022
36347846The Hippo signalling pathway and its implications in human health and diseases.Signal Transduct Target Ther2022
36319062Tanshinone functions as a coenzyme that confers gain of function of NQO1 to suppress ferroptosis.Life Sci Alliance2022
35256775Itaconate inhibits TET DNA dioxygenases to dampen inflammatory responses.Nat Cell Biol2022
35217640Transcriptional repression of estrogen receptor alpha by YAP reveals the Hippo pathway as therapeutic target for ER<sup>+</sup> breast cancer.Nat Commun2022
35177479Rag GTPases regulate cellular amino acid homeostasis.Proc Natl Acad Sci U S A2022
35294906Rheb regulates nuclear mTORC1 activity independent of farnesylation.Cell Chem Biol2022
  • 1 - 50 of 864

Recommended Authors

Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2015
Number of shared co-authors 3
College of Horticulture, China Agricultural University
Career Start Year 2012
Number of shared co-authors 1
Institut Curie, PSL Research University
Career Start Year 2011
Number of shared co-authors 2
Institute for Research in Immunology and Cancer (IRIC), Universite de Montreal
Career Start Year 2004
Number of shared co-authors 0
Institute for Research in Immunology and Cancer (IRIC)
Career Start Year 2004
Number of shared co-authors 2
Ben-Gurion University of the Negev
Career Start Year 2002
Number of shared co-authors 10
Cancer Stem Cell Research Center, Samsung Biomedical Research Institute
Career Start Year 2001
Number of shared co-authors 1
Research Institute, National Cancer Center
Career Start Year 2000
Number of shared co-authors 0
University of Toulouse, CNRS
Career Start Year 1999
Number of shared co-authors 0
University of Dundee
Career Start Year 1999
Number of shared co-authors 3
Department of Pharmaceutical Sciences, University of Toronto
Career Start Year 1999
Number of shared co-authors 4
IRIC - University of Montreal
Career Start Year 1998
Number of shared co-authors 2
Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 1995
Number of shared co-authors 2
The Institute of Biomedical Sciences, East China Normal University
Career Start Year 1994
Number of shared co-authors 1
University of Georgia
Career Start Year 1994
Number of shared co-authors 4
Lunenfeld-Tanenbaum Research Institute
Career Start Year 1994
Number of shared co-authors 9
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1994
Number of shared co-authors 6
Hospital for Sick Children
Career Start Year 1993
Number of shared co-authors 1
Case Western Reserve University School of Medicine
Career Start Year 1993
Number of shared co-authors 7
Lilly Research Laboratories
Career Start Year 1992
Number of shared co-authors 2
University of Dundee
Career Start Year 1992
Number of shared co-authors 1
Amsterdam University Medical Center
Career Start Year 1989
Number of shared co-authors 1
Oregon Health and Science University
Career Start Year 1987
Number of shared co-authors 5
Hospital for Sick Children, University of Toronto
Career Start Year 1985
Number of shared co-authors 2
Institute for Research in Immunology and Cancer
Career Start Year 1982
Number of shared co-authors 2
Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital
Career Start Year 1982
Number of shared co-authors 6
Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 1981
Number of shared co-authors 11
Broad Institute of MIT and Harvard
Career Start Year 1979
Number of shared co-authors 10
Frederick National Laboratory for Cancer Research
Career Start Year 1975
Number of shared co-authors 10
Salk Institute for Biological Studies
Career Start Year 1968
Number of shared co-authors 11

Collaborators

University of Miami Miller School of Medicine
Co-authored papers 26
Institute of Pediatrics, Children's Hospital of Fudan University
Co-authored papers 25
University of California
Co-authored papers 23
University of California, Los Angeles (university of california los angeles)
Co-authored papers 20
Kumamoto University
Co-authored papers 18
College of Life Science and Biotechnology, Yonsei University
Co-authored papers 16
University of California
Co-authored papers 16
Stanford University School of Medicine
Co-authored papers 11
University of California san francisco
Co-authored papers 10
Co-authored papers 6
Moores Cancer Center, University of California San Diego
Co-authored papers 5
Co-authored papers 5
Center for Epigenomics, University of California San Diego
Co-authored papers 5
Co-authored papers 4
Ludwig Institute for Cancer Research, University of California
Co-authored papers 4
School of Pharmacy, East China University of Science and Technology
Co-authored papers 4
College of Animal Science and Technology, Guangxi University
Co-authored papers 4
Duke University Medical Center
Co-authored papers 4
University of California
Co-authored papers 4
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
International Academy of Phronesis Medicine
Co-authored papers 3
University of Michigan Medical School.
Co-authored papers 3
Co-authored papers 3
Massachusetts General Hospital
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 3
University at Albany
Co-authored papers 2